<!DOCTYPE frameset SYSTEM "frameset.dtd">
<frameset>
  <predicate lemma="acetylate">
    <roleset id="acetylate.01" name="introduce an acetyl group into a compound">
      <aliases>
        <alias framenet="" pos="v" verbnet="">acetylate</alias>
        <alias framenet="" pos="n" verbnet="">acetylation</alias>
      </aliases>
      <note>ACETYLATE-V NOTES: Created for Bio-AMR annotations.</note>
      <roles>
        <role descr="agent of acetylation (e.g. scientist)" f="pag" n="0"/>
        <role descr="thing acetylated (material/source)" f="ppt" n="1"/>
        <role descr="instrument" f="mnr" n="2"/>
        <role descr="product of acetylation" f="prd" n="3"/>
      </roles>
      <example name="acetylate-v: patient and product of the reaction" src="" type="">
        <text>[The new NH2-terminal glycine]-1 is acetylated *-1 from acetyl-CoA when the polypeptide is 44 residues long.</text>
        <rel f="">acetylated</rel>
        <arg f="" n="3">*-1</arg>
        <arg f="" n="1">from acetyl-CoA</arg>
      </example>
      <example name="acetylate-v: agent and instrument" src="" type="">
        <text>We acetylated recombinant OGG1 with p300 (HAT domain) and confirmed acetylation by Western analysis with AcOGG1 antibody (Fig. 6A, lane 2).</text>
        <arg f="" n="0">We</arg>
        <rel f="">acetylated</rel>
        <arg f="" n="1">recombinant OGG1</arg>
        <arg f="" n="2">with p300 (HAT domain)</arg>
      </example>
      <example name="acetylation-n" src="" type="">
        <text>Acetylation of histones alters accessibility of chromatin</text>
        <rel f="">Acetylation</rel>
        <arg f="" n="1">of histones</arg>
      </example>
    </roleset>
  </predicate>
</frameset>
